ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Illinois Center Organizes Regional Cooperative Group

June 16, 1978

NCI Makes Its Pitch To OMB For Its First Billion Dollar Budget; Research Areas Listed By Priority

October 14, 1977

In Brief: Some Cancer Centers Funded At “Recommended” Levels For Fiscal 1981, But There Was A Catch

October 30, 1981

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994